Anúncio
Anúncio

RANI

RANI logo

Rani Therapeutics Holdings, Inc. Class A Common Stock

1.40
USD
Patrocinado
0.00
0.00%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

1.43

+0.03
+2.14%

Relatórios de Lucros RANI

Rácio de surpresa positiva

RANI separação 15 de 18 últimas estimativas.

83%

Próximo Relatório

Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/
--

Rani Therapeutics Holdings, Inc. Class A Common Stock earnings per share and revenue

On 06 de nov. de 2025, RANI reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.12 USD, resulting in a 4.61% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.01% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Rani Therapeutics Holdings, Inc. Class A Common Stock reported EPS of -$0.12, beating estimates by 4.61%, and revenue of $0.00, 0% as expectations.
The stock price moved down -11.01%, changed from $2.27 before the earnings release to $2.02 the day after.
The next earning report is scheduled for --.
Based on -- analistas, Rani Therapeutics Holdings, Inc. Class A Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio